STOCK TITAN

Vistagen Therapeutics Inc - VTGN STOCK NEWS

Welcome to our dedicated page for Vistagen Therapeutics news (Ticker: VTGN), a resource for investors and traders seeking the latest updates and insights on Vistagen Therapeutics stock.

Vistagen Therapeutics Inc (VTGN) is a clinical-stage biopharmaceutical company pioneering neuroscience-focused treatments through innovative stem cell technology. This page provides investors and industry professionals with essential updates on the company’s progress, including press releases, clinical trial milestones, and strategic developments.

Access real-time information on VTGN’s advancements in predictive toxicology, drug metabolism screening, and neuropsychiatric therapies. Our curated news collection ensures you stay informed about regulatory submissions, partnership announcements, and financial disclosures without needing to track multiple sources.

Key updates include progress in stem cell-derived bioassay systems, FDA communications regarding therapeutic candidates, and insights into the company’s unique approach to in vitro testing. All content is verified for accuracy and relevance to support informed decision-making.

Bookmark this page for streamlined access to VTGN’s latest developments. Check back regularly for authoritative reporting on advancements in neuroscience and biotechnology that could shape the future of drug discovery.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.68%
Tags
management
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.12%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
676.79%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.65%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.29%
Tags
none

FAQ

What is the current stock price of Vistagen Therapeutics (VTGN)?

The current stock price of Vistagen Therapeutics (VTGN) is $2.29 as of April 28, 2025.

What is the market cap of Vistagen Therapeutics (VTGN)?

The market cap of Vistagen Therapeutics (VTGN) is approximately 60.6M.
Vistagen Therapeutics Inc

Nasdaq:VTGN

VTGN Rankings

VTGN Stock Data

60.61M
28.79M
0.26%
52.64%
2.25%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO